Home › Overactive Bladder › NCT05652023
Noninvasive Ultrasound Assessment of Detrusor Dysfunction
RecruitingObservational study
Who can join
Ages 18 to 90 · All sexes
Full eligibility criteria
Inclusion Criteria: * Aim1: Age \>18 scheduled to undergo UDS for their clinical care for one of the included diagnoses. -Aim2: Inclusions: Age \>45 scheduled to undergo selective photovaporization of the prostate. Exclusion Criteria: * Aim1:Obesity (BMI \>35kg/m2), known neurologic disease impacting bladder function (e.g. spinal cord injury, multiple sclerosis, Parkinson's, prior cerebrovascular accident), previous pelvic radiation therapy, previous radical pelvic surgery (such as for uterine or colorectal cancer), prior bladder surgery (including prostate resection), and pregnant or breast-feeding women. * Aim2:Obesity (BMI \>35kg/m2), known neurologic disease impacting bladder function (e.g. spinal cord injury, multiple sclerosis, Parkinson's, prior cerebrovascular accident), previous pelvic radiation therapy, previous radical pelvic surgery (such as colorectal cancer).
About the study
The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.
Sponsor: Mayo Clinic · Participants: 2,023 · Started: Apr 20, 2023
Contact the study team
- Azra Alizad, MD · Phone: 5075381727
- Kathryn (Katie) Barthels · Phone: 5075385772
Official record on ClinicalTrials.gov — NCT05652023
Locations in the U.S.
| Minnesota | Mayo Clinic, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.